Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AMRXAMRX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in AMNEAL PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 3M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $52.2M as of 2026-Q2. The position was increased (+5.2% shares). AMRX represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$52.2M

Current Shares

3M

Total Value Change

+$44.5M

Total Shares Change

+2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3M
+5.2%
$52.2M0.0%$17.31
31
2026-Q1
Increased
2.9M
+11.0%
$35.6M0.0%$13.31
32
2025-Q4
Increased
2.6M
+4.9%
$32.5M0.0%$12.88
30
2025-Q3
Increased
2.5M
+10.1%
$24.6M0.0%$9.87
32
2025-Q2
Increased
2.2M
+138.5%
$18.1M0.0%$8.13
46
2025-Q1
Decreased
937,189
-3.8%
$7.9M0.0%$8.28
0
2024-Q4
New
973,745
-
$7.7M0.0%$7.83
38

Other major holders of AMRX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used